Brett E. Crawford

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor”.

Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor

Scientific Reports(2021)10.1038/s41598-021-93601-1

N/A

0DataRank · unranked

19 citations

Christina R. Mikulka, Bing Wang, Sanjay Chandriani, Sundeep Chandra, Yue Xu +14 more

Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome

Molecular Genetics and Metabolism(2021)10.1016/j.ymgme.2021.03.013

N/A

0DataRank · unranked

7 citations

Ibrahim Elsharkawi, Steven Q. Le, Heather Prill, Linley Mangini, Jonathan D. Cooper +5 more

Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001119

N/A

0DataRank · unranked

7 citations

Bethann Valentine, Andrew S. Hess, Jackie K. Jens, Elizabeth Snella, Maryam Jamil +32 more